LEMAITRE VASCULAR INC holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 108,962 | $9,141,912 | 0.16% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 15, 2025 |
| June 30, 2025 | 110,972 | $9,216,225 | 0.16% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 14, 2025 |
| Sept. 30, 2025 | 107,702 | $9,425,002 | 0.16% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 14, 2025 |
| Dec. 31, 2025 | 109,832 | $8,907,375 | 0.15% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 17, 2026 |
| March 31, 2026 | 111,876 | $12,213,503 | 0.21% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 15, 2026 |
| June 30, 2026 | 114,066 | $10,945,773 | 0.18% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 14, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.